Concepedia

Publication | Closed Access

The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy

DOI

27

Citations

14

References

2000

Year

Uğur Özerdem, Beata Mach-Hofacre, Lingyun Cheng, Sunan Chaidhawangul, Kelly Keefe, Charles D. McDermott, Germaine Bergeron-Lynn, Krzysztof Appelt, William R. Freeman
Current Eye Research

Abstract

Intravitreally administered prinomastat decreased development of PVR in an experimental model which made use of dispase to induce PVR.

References

YearCitations

Page 1